ICD-10-CM Billable Code

M11.06

Hydroxyapatite deposition disease, knee

Clinical Classification Guidelines

Medical Intelligence & Overview

Hydroxyapatite deposition disease (HADD) of the knee is a condition characterized by the abnormal buildup of hydroxyapatite crystals within the soft tissues around the knee joint. These deposits can cause pain, inflammation, and limited movement. HADD most commonly affects middle-aged and older adults and can significantly impact daily activities if left untreated. Understanding the causes, symptoms, and available management options can help in recognizing and addressing this condition promptly.

Causes & Symptoms

Clinical Causes: Accumulation of hydroxyapatite crystals in the soft tissues surrounding the knee Repetitive trauma or injury to the knee joint Degenerative changes associated with osteoarthritis Age-related changes in joint tissues Genetic predisposition influencing crystal formation Metabolic disorders that affect calcium and phosphate metabolism

Key Symptoms: Localized pain around the front or sides of the knee Swelling and tenderness over the affected area Stiffness and difficulty moving the knee A sensation of grinding or catching within the joint Redness and warmth in severe inflammatory cases Occasional catching or locking sensations during movement

Diagnostic & Treatment

Diagnosis Path: Diagnosing hydroxyapatite deposition disease involves a combination of clinical evaluation and imaging studies. A healthcare provider will review symptoms, medical history, and conduct a physical exam. Imaging techniques like X-rays often reveal characteristic deposits of calcium hydroxyapatite crystals around or within the knee tissues. In some cases, ultrasound or MRI scans are used to assess the extent of deposits and associated inflammation. Laboratory tests are generally not required for diagnosis but may be used to rule out other conditions.

Treatment Protocols: Management of HADD of the knee primarily aims to reduce pain and inflammation, restore joint function, and prevent recurrent crystal deposits. Common approaches include: - Non-steroidal anti-inflammatory drugs (NSAIDs) to control pain and swelling - Corticosteroid injections into the affected area for severe inflammation - Rest and activity modification to prevent further irritation - Physical therapy to improve joint mobility and strengthen surrounding muscles - Ultrasound-guided procedures to aspirate calcium deposits in some cases - Surgical intervention in rare, persistent cases to remove the deposits and repair damaged tissues Most cases respond well to conservative treatments, with symptoms often resolving over time. Preventive measures, such as managing underlying metabolic conditions and avoiding repetitive knee trauma, can help reduce recurrence.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M11.06 a billable ICD-10 code?
Yes, M11.06 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M11.06?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, knee and any associated comorbidities for accurate reporting.

Cite this Clinical Reference